Jan 5, 2000

Renal abnormalities in sickle cell disease

Kidney International
Phuong-Thu PhamS Q Lew

Abstract

Renal abnormalities in sickle cell disease. Sickle cell nephropathy is indicated by sickled erythrocytes, with the consequent effects of decreased medullary blood flow, ischemia, microinfarct and papillary necrosis. Impaired urinary concentrating ability, renal acidification, hematuria, and potassium secretion are also found. There may be a causal relationship between an increase in nitric oxide synthesis and experimental sickle cell nephropathy, and some studies have indicated that the progression of sickle cell nephropathy is hemodynamically mediated. Although there are many studies showing that proteinuria, nephrotic syndrome, chronic progressive renal failure, and acute renal failure syndromes are the outcome of this disease, the pathogenic mechanism(s) and potential therapies remain to be elucidated. Survival of patients with sickle cell nephropathy who progress to end-stage renal disease (ESRD) is equal to non-diabetic ESRD patients, and graft survival rates are also similar for those who undergo renal transplantation. This article presents a historical review of the glomerular and tubular disorders associated with sickle cell nephropathy, and reviews therapeutic indications to slow its progression. Further research is ne...Continue Reading

  • References38
  • Citations72

References

  • References38
  • Citations72

Mentioned in this Paper

Ischemia
Nitric Oxide Biosynthetic Process
Nephrotic Syndrome
Kidney Failure
Pathogenic Organism
Kidney Failure, Acute
Graft Survival
Renal Glomerular Disease
Proteinuria
Drepanocyte (Cell)

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

The American Journal of Surgical Pathology
C J DavisI A Sesterhenn
Journal of the American Medical Association
C A FRAZIER, C E RICE
© 2020 Meta ULC. All rights reserved